Femasys Inc (FEMY): Total Assets

Annual figures by period end, from SEC filings.

$20.72M
As of 2025-12-31
$12.29M
As of 2026-06-30
+7.0%
3-year compound annual growth
+22.2%
5-year compound annual growth
$28.58M2020-12-31: $7.61M2021-12-31: $28.58M2022-12-31: $16.90M2023-12-31: $27.76M2024-12-31: $12.45M2025-12-31: $20.72M$20.72M
2020-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$20.72M+66.5%2026-03-31, Balance as of period end
2024-12-31$12.45M-55.2%2026-03-31, Balance as of period end
2023-12-31$27.76M+64.3%2025-03-27, Balance as of period end
2022-12-31$16.90M-40.9%2024-03-28, Balance as of period end
2021-12-31$28.58M+275.7%2023-07-24, Balance as of period end
2020-12-31$7.61Mn/a2022-03-24, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Femasys Inc (FEMY)2025-12-31$20.72M+66.5%
QHSLab, Inc. (USAQ)2025-12-31$2.17M+20.6%
Vycor Medical Inc (VYCO)2025-12-31$830.4K-16.8%
OSR Health, Inc. (OSRH)2025-12-31$171.24M-2.3%
EBR Systems, Inc. (NONE.)2025-12-31$97.23M+32.2%
Nuo Therapeutics, Inc. (AURX)2025-12-31$1.85M+55.2%
IceCure Medical Ltd. (ICCM)2025-12-31$13.89M+10.4%
Tenon Medical, Inc. (TNON)2025-12-31$10.76M+9.3%
Intelligent Bio Solutions Inc. (INBS)2026-06-30$11.94M+44.8%

Compare FEMY, USAQ, VYCO, OSRH side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗